Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2021-02-17 3:10 pm Sale | 2020-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | Consonance Capital Management LP | 15,678 9.990% | -4,517![]() (-22.37%) | Filing History |
2021-02-17 3:09 pm Purchase | 2020-12-31 | 13G | CASI Pharmaceuticals, Inc. CASI | Consonance Capital Management LP | 757,643 6.110% | 151,793![]() (+25.05%) | Filing History |
2021-02-17 3:08 pm Sale | 2020-12-31 | 13G | AxoGen, Inc. AXGN | Consonance Capital Management LP | 0 0.000% | -6,058,505![]() (Position Closed) | Filing History |
2021-02-17 3:07 pm Sale | 2020-12-31 | 13G | Assembly Biosciences, Inc. ASMB | Consonance Capital Management LP | 164,156 5.970% | -340,719![]() (-67.49%) | Filing History |
2021-02-17 3:05 pm Sale | 2020-12-31 | 13G | ARQULE INC ARQL | Consonance Capital Management LP | 0 0.000% | -6,058,505![]() (Position Closed) | Filing History |
2021-02-17 3:05 pm Sale | 2020-12-31 | 13G | APTOSE BIOSCIENCES INC NO APTOF | Consonance Capital Management LP | 0 0.000% | -6,058,505![]() (Position Closed) | Filing History |
2021-02-17 2:23 pm Sale | 2020-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | Consonance Capital Management LP | 2,729,709 6.380% | -3,328,796![]() (-54.94%) | Filing History |
2021-02-17 2:22 pm Sale | 2020-12-31 | 13G | Aurinia Pharmaceuticals Inc. AUPH | Consonance Capital Management LP | 0 0.000% | -6,058,505![]() (Position Closed) | Filing History |
2021-02-17 2:22 pm Sale | 2020-12-31 | 13G | Omeros Corporation OMER | Consonance Capital Management LP | 0 0.000% | -6,058,505![]() (Position Closed) | Filing History |
2021-02-17 2:21 pm Sale | 2020-12-31 | 13G | CareDx, Inc CDNA | Consonance Capital Management LP | 0 0.000% | -6,058,505![]() (Position Closed) | Filing History |
2021-02-16 4:27 pm Unchanged | 2020-12-31 | 13G | Sio Gene Therapies Inc. SIOX | Consonance Capital Management LP | 6,058,505 9.990% | 0 (Unchanged) | Filing History |
2021-02-16 4:19 pm Purchase | 2020-12-31 | 13G | OXFORD IMMUNOTEC GLOBAL PLC OXFD | Consonance Capital Management LP | 6,058,505 11.000% | 6,058,505![]() (New Position) | Filing History |
2021-02-16 4:18 pm Purchase | 2020-12-31 | 13G | Assembly Biosciences, Inc. ASMB | Consonance Capital Management LP | 504,875 9.990% | 340,719![]() (+207.56%) | Filing History |
2021-02-16 4:09 pm Purchase | 2020-12-31 | 13G | APTOSE BIOSCIENCES INC NO APTOF | Consonance Capital Management LP | 6,058,505 11.000% | 6,058,505![]() (New Position) | Filing History |
2021-02-16 2:40 pm Purchase | 2020-12-31 | 13G | Sio Gene Therapies Inc. SIOX | Consonance Capital Management LP | 6,058,505 9.990% | 6,058,505![]() (New Position) | Filing History |
2021-02-16 2:40 pm Sale | 2020-12-31 | 13G | RETROPHIN, INC. RTRX | Consonance Capital Management LP | 0 0.000% | -2,314,421![]() (Position Closed) | Filing History |
2021-02-16 2:39 pm Sale | 2020-12-31 | 13G | OXFORD IMMUNOTEC GLOBAL PLC OXFD | Consonance Capital Management LP | 0 0.000% | -2,363,724![]() (Position Closed) | Filing History |
2021-02-16 2:38 pm Purchase | 2020-12-31 | 13G | Assembly Biosciences, Inc. ASMB | Consonance Capital Management LP | 164,156 5.970% | 7,623![]() (+4.87%) | Filing History |
2021-02-16 2:37 pm Sale | 2020-12-31 | 13G | APTOSE BIOSCIENCES INC NO APTOF | Consonance Capital Management LP | 0 0.000% | -4,772,190![]() (Position Closed) | Filing History |
2021-02-16 2:22 pm Purchase | 2020-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | Consonance Capital Management LP | 6,058,505 9.990% | 6,058,505![]() (New Position) | Filing History |